Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab vs Immunosuppressants in Pediatric Atopic Dermatitis
NCT04895423Phase 4Unknown
- Start
- Nov 2021
- Primary completion
- Jul 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in atopic dermatitis (AD). Status: unknown.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04895423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04895423.